NYSE:CRL
Charles River Laboratories International Stock News
$233.47
+3.58 (+1.56%)
At Close: May 03, 2024
ICLR vs. CRL: Which Stock Is the Better Value Option?
12:45pm, Monday, 29'th Apr 2024
Investors interested in stocks from the Medical Services sector have probably already heard of Icon PLC (ICLR) and Charles River Laboratories (CRL). But which of these two stocks presents investors wi
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
01:50pm, Wednesday, 24'th Apr 2024
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.
Here's Why You Should Retain Charles River (CRL) Stock Now
12:51pm, Tuesday, 16'th Apr 2024
Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.
ICLR or CRL: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 12'th Apr 2024
Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or Charles River Laboratories (CRL). But which of these two companies is the best option for t
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
08:00am, Friday, 12'th Apr 2024
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens.
Charles River (CRL) Forges Collaboration With Ship of Theseus
10:10am, Thursday, 11'th Apr 2024
Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
10:41am, Tuesday, 26'th Mar 2024
Charles River (CRL) announces the extension of the gene therapy manufacturing alliance with NUS Medicine.
Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report?
12:36pm, Friday, 15'th Mar 2024
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Charles River (CRL) Extends Gene Therapy Offering With New Pact
11:31am, Friday, 15'th Mar 2024
Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
Here's Why You Should Retain Charles River (CRL) Stock Now
10:51am, Thursday, 14'th Mar 2024
Investors remain optimistic about Charles River (CRL) due to the strength of the RMS segment.
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
04:00pm, Wednesday, 13'th Mar 2024
SOUTH SAN FRANCISCO, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman
The Top 3 Healthcare Stocks to Buy in March 2024
12:27pm, Thursday, 07'th Mar 2024
Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
Charles River (CRL) Forges Collaboration With Wheeler Bio
09:46am, Monday, 26'th Feb 2024
Charles River (CRL) and Wheeler Bio join forces to accelerate the journey from discovery and CMC development to manufacturing.
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
11:41am, Wednesday, 21'st Feb 2024
Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
01:19pm, Wednesday, 14'th Feb 2024
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript